Measuring Free Radicals in Human Sperm Cells Related to Microbiota and Lifestyle Factors

NCT ID: NCT05514223

Last Updated: 2024-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-06-01

Study Completion Date

2027-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The cause of infertility can be due to a female factor or a male factor. In case of a male factor, it is often due to poor semen quality. However, the cause of poor quality is often unknown. In previous research, infertility problems in men were related to chemical processes in metabolism causing the formation of free radicals. Free radicals are physiological by-products of our body mechanisms. Free radicals are very reactive and can therefore react with a lot of molecules of cells within our body and cause damage. A balance between free radicals, which are also needed for physiological processes in the body, and antioxidants, which defuses the reactive free radicals, is most desirable. However, as stated in literature, there are a lot of factors that can influence extra free radical production, which causes overloading of the system, resulting in damage on cellular level. Free radicals in semen plasma and on the sperm cell could play a role in male infertility. Nonetheless, free radicals are not used as diagnostic markers due to the lack of detection systems, as free radicals are very short-lived. This study aims to introduce a new technique, called diamond magnetometry, to measure free radicals directly on the sperm cell and in serum. Diamond magnetometry involves very small diamond particles as magnetic sensors that engage a reaction with the free radicals on the sperm cell, causing signals that can be measured. To compare local free radical production with systemic free radical production, other diagnostic biomarkers are also measured in serum.

It is hypothesized that the composition of seminal microbiome could influence the free radical concentration. Therefore, this study also aims to explore the microbiota composition and see if this has an influence in semen quality and free radical production. At last, this study also want to correlate standard semen parameters (defined by the World Health Organisation), lifestyle factors and food intake, to detect a role for lifestyle in the production of free radicals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To date, 15% of couples experience issues with fertility and in 40-50% of the cases it is thought to be due to fertility issues in men. Reactive oxygen species (ROS) and especially free radicals (the most reactive ones) play a key role in sperm capacitation and fertilisation. They are also believed to be a major contributor to male infertility. The free radical theory of infertility states that damage by free radicals is the main cause of infertility in males. However, they are difficult to measure due to their short lifetime and high reactivity.

Despite the relevance of free radicals, they are not used as diagnostic biomarkers nor as target for therapeutics since it is currently unknown where and when the free radicals are generated exactly, due to the insufficiency of the currently available techniques. Therefore, a new technique will be utilized called diamond magnetometry which allows nanoscale magnetic resonance measurements. This quantum sensing technique is uniquely sensitive and allows real-time single cell measurements with sub-cellular resolution. Unlike most other techniques this method is specific for free radicals. A first proof of principle experiment has been published in yeast cells and we have preliminary data which proofs that we can measure free radical generation in boar sperm. The concentration of free radicals will be related to standard semen-parameters according to the WHO guidelines, lifestyle factors and food intake and related with microbiota in semen plasma to explore possible correlations. Microbiota have been suggested to play a role in the context of reproduction. While several studies have been carried out focusing on the female reproductive system, less is known about male microbiota and its influence on fertility. In the past it was thought that the presence of bacteria in the semen was an indicator of infection. The next generation genetic-based approach has revealed that the human semen is not sterile and appear to host a specific microbiota. Alterations of the diversity of seminal microbiota or the abundance of specific bacteria have been associated with an altered morphology and motility of sperm cells. Nevertheless, the molecular processes through which bacteria are able to alter semen quality are unknown. Possible mechanisms may involve free radical damaging or alteration of other molecules (e.g. lipids peroxidation, DNA fragmentation) which may result in loss of fertilisation capability. Therefore, it is hypothesized that free radical generation is correlated to the diversity of microbiota and can be related to the semen-parameters defined by the WHO guidelines.

The primary objective of this study is to measure real-time free radicals in human single sperm cells using diamond magnetometry. This is correlated to the seminal microbiota composition to investigate the influence of the composition in free radical generation, and therefore a possible mechanism of microorganisms to alter semen quality. The free radical concentration is also related to other oxidative stress parameters in serum to compare local and systemic oxidative stress. At last, the free radical concentration will also be correlated to the semen analysis parameters (WHO guidelines), lifestyle factors and food intake to detect a role for lifestyle in free radical formation and semen quality.

The main study parameters will be the free radical concentration at sperm cells and serum, correlated with microbiota in seminal plasma and related to standard semen- parameters (WHO), malondialdehyde (MDA) and free thiols concentration in blood serum, lifestyle factors and food intake.

The patients are informed about the study at their intake at the Centre of Reproductive Medicine. After informed consent, patients will have to produce semen for evaluation in the context of standard care semen analysis. A sample of that ejaculate will be collected for the SIRIUS study to measure free radicals in. Next to that, blood will be drawn from the patients at the same day as the semen analysis for the free radical measurement in serum.

Free radical measurements will be performed using diamond magnetometry. Previously, diamond magnetometry was successfully used to quantify radical formation in the acrosome of boar sperm heads. This allowed quantification of radical formation locally in real time, during capacitation. This data is not published yet and is produced in the lab of Dr. Romana Schirhagl.

Semen plasma microbiota composition will be evaluated using quantitative polymerase chain reaction (qPCR) and 16S ribosomal ribonucleic acid (rRNA) sequencing methods using QIAGEN Sample and Assay Technologies.

MDA concentration in serum will be measured using Thio barbituric acid reactive substance (TBARS) assay. Free thiol concentration in serum will be measured using the Ellman technique. A questionnaire for lifestyle factors is implemented as part of standard care for the couples seeking fertility treatment. These outcomes and answers will also be used for SIRIUS.

For an indication of food intake of the subjects a food frequency questionnaire (FFQ) of Wageningen University will be used.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility, Male Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Males of couples seeking fertility treatment

The study population will consist of males of couples that visit the Center reproductive Medicine of the UMCG where a semen analysis is planned for clinical purposes.

Biomaterial collection for observational purpose

Intervention Type OTHER

The semen will be collected to measure the free radical concentration in seminal plasma and sperm together with the diversity of microbiota. Both males with a normal semen analysis (SA) and abnormal SA according to the WHO guidelines (2010) will be included. Blood plasma will be collected to measure systemic radical concentration and all outcomes will be related to lifestyle factors and food intake acquired through hospital charts and routinely conducted questionnaires together with a food frequency Questionnaire (FFQ).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biomaterial collection for observational purpose

The semen will be collected to measure the free radical concentration in seminal plasma and sperm together with the diversity of microbiota. Both males with a normal semen analysis (SA) and abnormal SA according to the WHO guidelines (2010) will be included. Blood plasma will be collected to measure systemic radical concentration and all outcomes will be related to lifestyle factors and food intake acquired through hospital charts and routinely conducted questionnaires together with a food frequency Questionnaire (FFQ).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males of couples visiting the CRM at the UMCG between 18-55 years old.
* Planned semen-analysis as standard care.

Exclusion Criteria

* Males who receive(d) chemo- and/or radiotherapy, use(d) testosterone suppletion and/or anabolic steroids
* Males who are azoospermic
* Males who have an abnormal SA due to genetic causes.
* Semen analysis with round cells \>2x106 /ml (as marker for infection)
* Males who currently use antibiotics
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Medical Center Groningen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Astrid EP Cantineau

Role: PRINCIPAL_INVESTIGATOR

University Medical Centre Groningen; Centre of Reproductive Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Medical Centre Groningen

Groningen, , Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Astrid EP Cantineau, Dr.

Role: CONTACT

+31(0)50-3613032

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Astrid E.P. Cantineau, Dr.

Role: primary

050-3613008

References

Explore related publications, articles, or registry entries linked to this study.

Kumar N, Singh AK. Trends of male factor infertility, an important cause of infertility: A review of literature. J Hum Reprod Sci. 2015 Oct-Dec;8(4):191-6. doi: 10.4103/0974-1208.170370.

Reference Type BACKGROUND
PMID: 26752853 (View on PubMed)

Tomaiuolo R, Veneruso I, Cariati F, D'Argenio V. Microbiota and Human Reproduction: The Case of Female Infertility. High Throughput. 2020 May 3;9(2):12. doi: 10.3390/ht9020012.

Reference Type BACKGROUND
PMID: 32375241 (View on PubMed)

Mamin HJ, Kim M, Sherwood MH, Rettner CT, Ohno K, Awschalom DD, Rugar D. Nanoscale nuclear magnetic resonance with a nitrogen-vacancy spin sensor. Science. 2013 Feb 1;339(6119):557-60. doi: 10.1126/science.1231540.

Reference Type BACKGROUND
PMID: 23372008 (View on PubMed)

Baud D, Pattaroni C, Vulliemoz N, Castella V, Marsland BJ, Stojanov M. Sperm Microbiota and Its Impact on Semen Parameters. Front Microbiol. 2019 Feb 12;10:234. doi: 10.3389/fmicb.2019.00234. eCollection 2019.

Reference Type BACKGROUND
PMID: 30809218 (View on PubMed)

Weng SL, Chiu CM, Lin FM, Huang WC, Liang C, Yang T, Yang TL, Liu CY, Wu WY, Chang YA, Chang TH, Huang HD. Bacterial communities in semen from men of infertile couples: metagenomic sequencing reveals relationships of seminal microbiota to semen quality. PLoS One. 2014 Oct 23;9(10):e110152. doi: 10.1371/journal.pone.0110152. eCollection 2014.

Reference Type BACKGROUND
PMID: 25340531 (View on PubMed)

Thoma ME, McLain AC, Louis JF, King RB, Trumble AC, Sundaram R, Buck Louis GM. Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach. Fertil Steril. 2013 Apr;99(5):1324-1331.e1. doi: 10.1016/j.fertnstert.2012.11.037. Epub 2013 Jan 3.

Reference Type BACKGROUND
PMID: 23290741 (View on PubMed)

Hou D, Zhou X, Zhong X, Settles ML, Herring J, Wang L, Abdo Z, Forney LJ, Xu C. Microbiota of the seminal fluid from healthy and infertile men. Fertil Steril. 2013 Nov;100(5):1261-9. doi: 10.1016/j.fertnstert.2013.07.1991. Epub 2013 Aug 29.

Reference Type BACKGROUND
PMID: 23993888 (View on PubMed)

Agarwal A, Rana M, Qiu E, AlBunni H, Bui AD, Henkel R. Role of oxidative stress, infection and inflammation in male infertility. Andrologia. 2018 Dec;50(11):e13126. doi: 10.1111/and.13126.

Reference Type BACKGROUND
PMID: 30569652 (View on PubMed)

DiGuiseppi J, Fridovich I. The toxicology of molecular oxygen. Crit Rev Toxicol. 1984;12(4):315-42. doi: 10.3109/10408448409044213.

Reference Type BACKGROUND
PMID: 6204814 (View on PubMed)

Ciobanu L, Seeber DA, Pennington CH. 3D MR microscopy with resolution 3.7 microm by 3.3 microm by 3.3 microm. J Magn Reson. 2002 Sep-Oct;158(1-2):178-82. doi: 10.1016/s1090-7807(02)00071-x.

Reference Type BACKGROUND
PMID: 12419685 (View on PubMed)

Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, Haugen TB, Kruger T, Wang C, Mbizvo MT, Vogelsong KM. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010 May-Jun;16(3):231-45. doi: 10.1093/humupd/dmp048. Epub 2009 Nov 24.

Reference Type BACKGROUND
PMID: 19934213 (View on PubMed)

Farahani L, Tharakan T, Yap T, Ramsay JW, Jayasena CN, Minhas S. The semen microbiome and its impact on sperm function and male fertility: A systematic review and meta-analysis. Andrology. 2021 Jan;9(1):115-144. doi: 10.1111/andr.12886. Epub 2020 Oct 7.

Reference Type BACKGROUND
PMID: 32794312 (View on PubMed)

Bourgonje AR, Gabriels RY, de Borst MH, Bulthuis MLC, Faber KN, van Goor H, Dijkstra G. Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease. Antioxidants (Basel). 2019 Sep 1;8(9):351. doi: 10.3390/antiox8090351.

Reference Type BACKGROUND
PMID: 31480545 (View on PubMed)

Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med. 1990;9(6):515-40. doi: 10.1016/0891-5849(90)90131-2.

Reference Type BACKGROUND
PMID: 2079232 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

202100341

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Contraception in Normal and Subnormal Men
NCT00167141 TERMINATED PHASE2